KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Return on Capital Employed (2016 - 2026)

Medtronic's Return on Capital Employed history spans 12 years, with the latest figure at 7.36% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 23.0% to 7.36% in Q1 2026 year-over-year; TTM through Jan 2026 was 7.36%, a 23.0% increase, with the full-year FY2025 number at 7.64%, up 118.0% from a year prior.
  • Return on Capital Employed hit 7.36% in Q1 2026 for Medtronic, down from 7.65% in the prior quarter.
  • Over the last five years, Return on Capital Employed for MDT hit a ceiling of 7.88% in Q3 2022 and a floor of 6.46% in Q2 2024.
  • Historically, Return on Capital Employed has averaged 7.14% across 5 years, with a median of 7.05% in 2023.
  • Biggest five-year swings in Return on Capital Employed: surged 306bps in 2022 and later plummeted -100bps in 2023.
  • Tracing MDT's Return on Capital Employed over 5 years: stood at 7.6% in 2022, then decreased by -9bps to 6.89% in 2023, then increased by 1bps to 6.96% in 2024, then increased by 10bps to 7.65% in 2025, then fell by -4bps to 7.36% in 2026.
  • Business Quant data shows Return on Capital Employed for MDT at 7.36% in Q1 2026, 7.65% in Q4 2025, and 7.67% in Q3 2025.